BusinessCempra to Present at Three Upcoming Investor ConferencesBy Nasdaq OMXSep 1, 2016, 11:30 AM UTC
BusinessCempra to Present Solithromycin at FDA Antimicrobial Drugs Advisory Committee Meeting on November 4, 2016By Nasdaq OMXAug 30, 2016, 1:15 PM UTC
BusinessCempra’s Pivotal Phase 3 SOLITAIRE-IV Study of IV to Oral Solithromycin Published in Clinical Infectious DiseasesBy Nasdaq OMXAug 25, 2016, 8:05 PM UTC
